- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Pharmaceutical Product Development, Inc. (NASDAQ:PPDI) as its December 2008 "Stock to Study" and eBay Inc. (NASDAQ:EBAY) as its December "Undervalued Stock" for investors’ informational and educational use.
“The committee chose Pharmaceutical Product Development, a contract research firm that provides drug discovery and development services, because of the company's history of robust growth, continued prospects and rock-solid financial strength," said Adam Ritt, editor of BetterInvesting Magazine. "For the Undervalued selection, the committee believes that eBay has several high-growth revenue streams to help it weather a slowdown in the economy and that the stock's valuation is currently quite reasonable." Check BetterInvesting Magazine's December issue for a detailed review of each company.
Committee members are Robert M. Bilkie, Jr., CFA; Daniel J. Boyle, CFA; Philip S. Dano, CFA; Donald E. Danko, CFA; Maury Elvekrog, CFA; Kenneth S. Janke, Sr.; Walter J. Kirchberger, CFA; Marisa Lenhard, CFA; and Donald T. Spindel, CFA.
As stated, the BetterInvesting committee’s Stock to Study and Undervalued Stock choices are for the informational and educational uses of investors and are not intended as investment recommendations. BetterInvesting urges investors to educate themselves about the stock market so they can make informed decisions about stock purchases.
BetterInvesting Magazine is published monthly by BetterInvesting.
BetterInvesting is the brand identity of the National Association of Investors Corporation, a national, nonprofit association with members consisting of individual investors and investment clubs. Founded in 1951 and with headquarters in Madison Heights, Mich., BetterInvesting is considered the voice of the individual investor, as well as the pioneer of the modern investment club movement. BetterInvesting is dedicated to providing a sound program of investment education and information to help its members become successful long-term, lifetime investors.